A hybrid bioprinting-electrospinning platform integrating nanofibers and mesenchymal cell spheroids for customizable wound healing dressings

Seyede Atefe Hosseini,Viktoria Planz,Ernst H. K. Stelzer,Maike Windbergs,Francesco Pampaloni

DOI: https://doi.org/10.1101/2024.09.14.613065

2024-09-16

Abstract:We introduce a platform for the fabrication of customizable wound healing dressing. The platform integrates electrospun nanofibers, bioprinted hydrogels, and cellular spheroids into hierarchical, fiber-reinforced hybrid constructs. The construct leverages the mechanical strength of polycaprolactone (PCL) nanofibers and the ECM-like properties of GelMA/PEGDA hydrogel. These materials support the incorporation of bone marrow-derived mesenchymal stem cell (BM-hMSC) spheroids, which act as a supportive “cell niche,” enhancing the viability of the hMSC during and after bioprinting, and facilitating their spreading across the construct during the maturation phase. The characterization of the hybrid constructs demonstrated strong structural integrity and enhanced mechanical properties, making them well-suited for clinical wound dressing applications. assays, including live/dead staining, MTT assays, and scratch assays, revealed increased cell attachment, proliferation, and migration. The spheroids maintained their viability over extended periods, significantly contributing to wound closure in the scratch assay. This innovative approach, which combines electrospinning and light-based bioprinting, offers a promising strategy for the development of customizable wound dressings that closely adapt to the complex architecture of human skin. The bioprinting approach allows for the creation of tailored geometries for specific clinical requirements. Future research will focus on optimizing scaffold design and conducting long-term studies to validate the platform’s clinical potential.

Cell Biology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a customized dressing that can effectively promote wound healing. Specifically, the researchers combined electrospinning technology and light - based bioprinting technology to create a hybrid biological construct integrating nanofibers and mesenchymal stem cell spheroids. This construct aims to overcome the deficiencies of existing hydrogel models in terms of mechanical strength and new synthesis of extracellular matrix (ECM), providing a wound dressing with stronger structural integrity and mechanical properties, which is especially suitable for the treatment of complex wounds such as diabetic wounds.

The key points mentioned in the paper include:
- **Material selection**: Polycaprolactone (PCL) nanofibers are used to provide mechanical strength, and GelMA/PEGDA hydrogel is used to provide biocompatibility and support cell proliferation.
- **Cellular components**: Bone marrow - derived mesenchymal stem cell (BM - hMSC) spheroids are introduced as "cell reservoirs". These spheroids not only improve the survival rate of cells during the printing process but also promote the diffusion and maturation of cells throughout the construct.
- **Functional verification**: Through a series of in vitro experiments (such as live/dead staining, MTT assay, scratch test, etc.), the cell attachment, proliferation, and migration abilities of the construct are verified, showing its potential in promoting wound closure.

Overall, the goal of this research is to develop a new type of wound dressing through an innovative combination of technologies, which can serve as a physical barrier to prevent further damage and infection, promote wound closure, accelerate healing, and reduce scar formation.